Furtmüller PG
ORCID: 0000-0002-1199-2469
· 1 paper in corpus
2018
There is an increasing interest in developing novel eosinophil peroxidase (EPO) inhibitors, in order to provide new treatment strategies against chronic inflammatory and neurodegenerative diseases caused by eosinophilic disorder. Within thi…